Liftstream is an executive search recruitment company in the life sciences sector
Covagen raises $63m for targeted antibody work
Authored by Karl Simpson
Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business
Tagged ANTI TNF/IL-17A, antibody, Ascent Biomedical Ventures, Avi Kometz, bispecific, COVA322, Covagen, Dr Dragan Grabulovski, Dr Julian Bertschinger, Dr Karl Naegler, Edmond de Rothschild], Elias Papatheodorou, ETH Zurich, Fynomers, Gimv, Investment, Medigene, Merck Serono, Micromet, Mitsubishi Tanabe Pharma Corporation, MP Healthcare Venture Management, Novartis Venture Fund, Prof Christoph Lengauer, Roche, Seroba Kernel Life Sciences, Sir Greg Winter, Third Rock Ventures, trispecific, Ventech, venture capital
Leave a comment
Roche scores conditional European win with Erivedge
Authored by Karl Simpson
Posted in Pharmaceutical business
Tagged antibody, ASCO, basal cell carcinoma, BCC, BMS, CHMP, Conditional approval, conditional marketing authorization, CUDC-907, Curis Inc, EMA, Erivedge, europe, European Commission, Genentech, HDAC inhibitor, IAP proteins, immunotherapy, Melanoma, Merck, MPDL3280A, oncolgy, PD-1, PI3K, Roche, vismodegib
Leave a comment